Onco-Innovations Announces Amendment to Private Placement Pricing

February 12, 2026 9:00 AM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") announces that it has amended the pricing of its previously-announced (see news release dated January 23, 2026) non-brokered private placement (the "Amended Private Placement"). Under the Amended Private Placement, the Company intends to issue up to 3,076,9233 units (each, a "Unit'') at a price of $0.65 per Unit, for aggregate gross...

Read more

ZetrOZ Systems Brings Wearable Ultrasound Technology to Pro Baseball's Spring Training

February 12, 2026 9:00 AM

As pitchers and catchers report next week to baseball's spring training camps, ZetrOZ Systems will also be there, meeting with teams to present its sustained acoustic medicine (sam®) technology. The company's sam® wearable ultrasound device is proven effective in helping athletes recover from workouts, avoid health issues and recover more quickly from common soft-tissue injuries. ZetrOZ Systems has previously worked with the Professional...

Read more

AGFA HealthCare Accelerates U.S. Growth with Strategic Enterprise Imaging Wins

February 12, 2026 8:30 AM

AGFA HealthCare continued its strong business momentum across the U.S. market, as health systems expand their use of scalable, cloud-based Enterprise Imaging solutions that support clinical efficiency, clinical collaboration, and organizational growth.A key highlight of this momentum is a new agreement with a rapidly growing, multi-state radiology group - delivering diagnostic imaging and professional reading services across 11 sites in four...

Read more

MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides

February 12, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has filed an application for Orphan Drug Designation (ODD) for "NV-387 as a Treatment for MPox" with the US FDA Office of Orphan Products Development (OOPD).If approved,...

Read more

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))

February 12, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the filing of a provisional patent application with the United States Patent and Trademark Office (USPTO). The application, titled "A Sublingual Powder Formulation of Ondansetron and Methods of Use Thereof," marks the first-ever sublingual powder delivery system...

Read more

Medicus Pharma on Bloomberg World

February 12, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, CEO Dr Raza Bokhari joined Matt Miller from Bloomberg World for a live interview on February 10, 2026. https://youtu.be/2-naOb7uJRc?si=eumsbejKNkAdQ62GIn this live interview on Bloomberg World, Dr. Raza Bokhari, Executive...

Read more

Best Thyroid Support Supplements in 2026. Consumer Guide and Analysis

February 12, 2026 7:20 AM

What Thyroid Support Supplements Are and Why People Use Them in 2026By 2026, thyroid support supplements are no longer a narrow or misunderstood category. They have become part of a broader discussion around nutritional balance, daily consistency, and long-term wellness routines.As consumer awareness has increased, so has the demand for supplements that are clearly explained, responsibly formulated, and easy to integrate into everyday life....

Read more

DNDi and Dubai Health Sign a Partnership to Advance Research and Training in Neglected Diseases

February 12, 2026 4:30 AM

Dubai Health has signed a Memorandum of Understanding (MoU) with the non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) at World Health Expo Dubai (WHX). The agreement was signed by Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences, and Dr. Luis Pizarro, Executive Director of the Drugs for Neglected...

Read more

Genflow Biosciences PLC Announces Preliminary Interim Results From Dog Study

February 12, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a European-based biotechnology company focused on the development of gene therapies for age-related diseases, announces positive preliminary interim results from its SLAB (Sarcopenia and Longevity in Aged Beagles) clinical trial evaluating its proprietary SIRT6 centenarian gene therapy in aged dogs.Trial overviewThe randomised, blinded study, conducted by an...

Read more

Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025

February 11, 2026 4:30 PM

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2025.Revenue for the quarter ended December 31, 2025 was $11.3 million compared to $12.6 million for the quarter ended December 31, 2024, a decrease of $1.3 million or 10.3%. The Company had an operating loss of $0.9 million in the quarter ended December 31, 2025 compared to operating income in the quarter ended...

Read more

Abound Health Acquires Pro Care Unlimited, Expanding Its Mission and Services into Michigan

February 11, 2026 2:40 PM

In a move that marks a significant milestone in its continued growth, Abound Health is proud to announce its acquisition of Pro Care Unlimited, a trusted provider of personal care and community living supports in Michigan. Effective January 1, 2026, Pro Care Unlimited officially joined the Abound Health family, bringing together two organizations with shared values and a commitment to high-quality, person-centered care.Founded more than 20 years...

Read more

Rythmia Life Advancement Center Surpasses $1 Million in Scholarship Awards, Sending 156 Recipients to Medically Licensed Ayahuasca Retreat

February 11, 2026 1:50 PM

Rythmia Life Advancement Center, the world's only medically licensed plant medicine center, which recently celebrated 10 years in business, today announced that its Scholarship Program has awarded more than $1,008,105 in full retreat scholarships to 156 recipients - a milestone that underscores the center's commitment to making transformative plant medicine experiences accessible regardless of economic background.The Rythmia Scholarship Program...

Read more

New Analysis Finds Global Drug Pricing Benchmarking May Fall Short on Affordability

February 11, 2026 1:30 PM

A new report by Aimed Alliance, international patient advocates, and advocacy organizations, found that due to the United States' unique health care system, an international reference pricing program, such as those proposed under the Centers for Medicare and Medicaid Services (CMS) GUARD and GLOBE models, may not meaningfully improve affordability for consumers.Aimed Alliance's new analysis, International Reference Pricing: Lessons Learned from...

Read more

AMEEREX CORPORATION (OTC: HIRU) Issues Complementary Clarification to January 7, 2026, Press Release: ~US$66 Billion In-Situ Lithium Resource; Structured Dual Exposure

February 11, 2026 11:20 AM

ATLANTA, GA and DOHA, QATAR / ACCESS Newswire / February 11, 2026 / Ameerex Corporation (OTC:HIRU) ("Ameerex" or the "Company" provides this complementary clarification to its press release dated January 7, 2026, to ensure the market clearly understands the scale and structure of its lithium participation framework and updates the underlying lithium resource value based on current battery-grade lithium carbonate pricing.Patagonia Lithium has...

Read more

Newest Issue of Chairside(R) Magazine Connects AI with Reshaping Dental Success

February 11, 2026 11:00 AM

Volume 21, Issue 1, of Chairside® magazine is now available in print and online at chairsidemagazine.com - offering four CEUs."In this issue of Chairside magazine," said founder and president, Jim Glidewell, "we highlight how AI makes diagnosis more precise, treatment planning simpler, intraoral scanning more powerful, implant placement more predictable, and chairside milling more accessible. I encourage readers to explore this issue and...

Read more

15th Annual Resident of Distinction Award Recipients Recognized at Maui Derm Hawaii 2026

February 11, 2026 10:20 AM

DermMentors™ announced today that as part of the 15th Annual dermMentors™ Resident of Distinction Award™, Beiersdorf Inc. sponsored five top dermatology residents to attend the 2026 Maui Derm Hawaii conference, held in Wailea Beach, Maui, Hawaii, from January 25-29, 2026.As selected by the dermMentors™ Faculty, the Resident Awardees - Nagasai Adusumilli, MD, MBA, of George Washington University, Anna Catinis, MD, of the Baylor College of...

Read more

EDGE Surgical Signs $100,000+ Distribution Agreement with BioIntegris to Drive Ortho EDG(R) Adoption Throughout Cincinnati Metro Area

February 11, 2026 9:00 AM

EDGE Surgical, Inc., the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, has announced a $120,000 agreement with BioIntegris to serve as an authorized distributor for the Ortho EDG® Universal Electronic Depth Gauge in the greater Cincinnati area.This relationship arrives at a critical time, driven by the growing demand for the Ortho EDG®. BioIntegris will distribute the innovative EDGE Surgical product...

Read more

Invitation to Presentations of Senzime's Q4 and Year-End Report 2025

February 11, 2026 8:00 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter and year-end report for 2025 on February 18, 09:00 CET. The report will be published during the morning of the same day.Philip Siberg, CEO of Senzime, will present the report through a webcast available at Senzime's website https://www.senzime.com/investorsIn the afternoon of February 18, Gustaf Meyer, analyst at...

Read more

Gallardo Periodontics Highlights Early Steps to Prevent Gum Disease and Tooth Loss

February 11, 2026 8:00 AM

Gum disease remains one of the most common oral health conditions affecting adults, yet many people are unaware of how early symptoms can lead to long-term damage if left untreated. At Gallardo Periodontics and Implant Dentistry, leading Miami periodontist Dr. John Paul Gallardo is emphasizing the importance of early prevention and consistent periodontal care to help patients protect their gums, preserve their natural teeth, and support overall...

Read more

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

February 11, 2026 7:45 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that it has entered into a securities purchase agreement on February 6, 2026 (the "Securities Purchase Agreement") with select institutional and accredited investors (collectively, the "Investors") for the purchase and sale of up to 26,250 shares of Series A...

Read more